Galapagos and Gilead Discontinue Phase 3 ISABELA Program of Ziritaxestat in IPF
Galapagos and Gilead have halted the phase 3 ISABELA program, consisting of two studies evaluating ziritaxestat in patients with idiopathic […]
Sleep Apnea is a Risk Factor for Severe COVID-19
A group of Finish and American research study results show that COVID-19 outcome is mediated primarily through respiratory distress. Risk […]
Amgen, AstraZeneca Report Phase 3 NAVIGATOR Trial of Tezepelumab Meets Primary Endpoint in Patients with Severe Asthma
Amgen and AstraZeneca announced positive results from NAVIGATOR, a phase 3 trial evaluating tezepelumab versus placebo, both added to standard […]
Pfizer Presents Phase 2 and 3 Data from its 20-valent Pneumococcal Conjugate Vaccine (20vPnC) Candidate
Pfizer presented data from a phase 3 trial of its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate in adults 18 years […]
Regeneron and Sanofi Announce Dupixent Effective in Phase 3 Pediatric Asthma Trial
Regeneron and Sanofi announced positive results from the phase 3 LIBERTY ASTHMA VOYAGE trial which evaluated Dupixent (dupilumab) in children aged […]
Corbus Pharma’s Lenabasum Fails to Meet Endpoints in Phase 2b Cystic Fibrosis Trial
Corbus Pharmaceuticals announced topline results from its 28-week Phase 2b study (CF-002) of lenabasum in patients with cystic fibrosis (CF). […]
AstraZeneca’s Tagrisso Effective in Treating Patients with EGFR-mutated Lung Cancer with CNS Metastases
AstraZeneca presented data from its ADAURA Phase III trial showing that Tagrisso (osimertinib) demonstrated clinically meaningful improvement in central nervous […]
University of Southampton Spinoff Phase 2 Results Evidence SNG001 Reduces Chance of COVID-19 Severity as Stock Price Erupts
UK-based, publicly traded Synairgen’s stock (LSE:SNG) price exploded recently after positive clinical trial results, while the company has to issue […]
UK Gov Approves as U.S. HHS Places Dexamethasone on Treatment Guidelines; Demand Soars & More Data Needed
The government of the United Kingdom (UK) approved dexamethasone, a commonly prescribed steroid treatment, as a COVID-19 therapy thanks to […]
Acceleron Presents Topline Results of Phase 2 PULSAR Trial of Sotatercept for Pulmonary Arterial Hypertension
Acceleron Pharma presented positive topline results from the phase 2 PULSAR trial evaluating sotatercept versus placebo for the treatment of […]
